Literature DB >> 1313042

Lupus anti-DNA antibodies bearing the 8.12 idiotype appear to be somatically mutated.

A Livneh1, E Behar, A Many, M Ehrenfeld, E Gazit, B Diamond.   

Abstract

Anti-DNA antibodies in systemic lupus erythematosus (SLE) sera were analyzed using an antiidiotype designated 8.12 which recognizes a determinant on lambda light chains highly expressed in SLE sera. Eight of ten normal individuals had peripheral blood lymphocytes which produced high-titered 8.12-positive antibodies, following transformation with Epstein Barr virus, implying that the 8.12-reactive sequence originates in the germline gene (GLG). Of 58 SLE sera, 32 contained elevated titers of 8.12-reactive antibodies. Twenty-three of these sera had 8.12-reactive anti-DNA antibodies, suggesting a strong correlation between 8.12 idiotype and DNA binding. Moreover, 20 of 26 8.12-reactive IgG antibodies and only 4 of 10 8.12-reactive IgM antibodies bound DNA (P less than 0.05). These observations strengthen our previous findings in myeloma sera that DNA binding is associated with IgG isotype in the 8.12 idiotype system and suggest that the acquisition of anti-DNA reactivity in antibodies bearing the GLG idiotype 8.12 is achieved by somatic mutation, a feature of an antigen-driven response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313042     DOI: 10.1007/bf00918267

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

1.  Preferential expression of the systemic lupus erythematosus-associated idiotype 8.12 in sera containing monoclonal immunoglobulins.

Authors:  A Livneh; J L Preud'Homme; A Solomon; B Diamond
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

2.  Analysis of variable region genes encoding a human anti-DNA antibody of normal origin. Implications for the molecular basis of human autoimmune responses.

Authors:  E Cairns; P C Kwong; V Misener; P Ip; D A Bell; K A Siminovitch
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

3.  A cross-reactive idiotype on anti-DNA antibodies defines a H chain determinant present almost exclusively on IgG antibodies.

Authors:  A Davidson; A Smith; J Katz; J L Preud'Homme; A Solomon; B Diamond
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

4.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse.

Authors:  M J Shlomchik; A H Aucoin; D S Pisetsky; M G Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Somatic diversification of the S107 (T15) VH11 germ-line gene that encodes the heavy-chain variable region of antibodies to double-stranded DNA in (NZB x NZW)F1 mice.

Authors:  S M Behar; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  Lupus serum and normal human serum contain anti-DNA antibodies with the same idiotypic marker.

Authors:  M P Madaio; A Schattner; M Shattner; R S Schwartz
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

7.  Idiotypes of monoclonal anti-DNA antibodies produced in autoimmune B/W mice are expressed in normal mice.

Authors:  L Jacob; F Tron; M A Lety; J F Bach
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

8.  A rapid ELISA for measurement of antibodies to nucleic acid antigens using UV-treated polystyrene microplates.

Authors:  M Zouali; B D Stollar
Journal:  J Immunol Methods       Date:  1986-06-10       Impact factor: 2.303

9.  Use of monoclonal antibodies to identify shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus.

Authors:  G Solomon; J Schiffenbauer; H D Keiser; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  A novel class of anti-DNA antibodies identified in BALB/c mice.

Authors:  R Shefner; G Kleiner; A Turken; L Papazian; B Diamond
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.